Cleave Therapeutics
San Francisco, CA
Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.
cleavetherapeutics.comCompany Details
Founded
- 2011
Employees
- Between 10 - 20 employees
Raised
- $101,000,000
Headquarters Location
- San Francisco, CA
Public
- No
Acquired
- No
CEO
Amy Burroughs
Founders
- Peter ThompsonRaymond Deshaies
Company Collections
These are collections Cleave Therapeutics is a part of. Click on the collection name to view similar companies.